García-Quintanilla JF, Sanchez-Frias O, Espinoza SI, Ruiz-Chapa E, Zavala LA, Martínez-Sáenz G, Ruiz FJ

Language: Spanish
References: 17
Page: 308-313
PDF size: 309.76 Kb.

ABSTRACT

Bi-parametric magnetic resonance imaging has become a mayor tool in the detection of suspect prostate cancer as been proven in the present report. This and other recent reports should change the approach instead multiple random biopsies for target prostate biopsies.

REFERENCES

1. Polascik TJ, Oesterling JF, Partin AW. Prostate specific antigen : A decade of discovery-what we have learned and where we are going. J Urol. 1999;162: 293-306.

2. Lawton C. Prostate Cancer: Improving the flow of research. Radiology. 2018;287:5-9.

3. Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging-initial results. Radiology. 2003;229:241-7.

4. Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D, et al. Transition zone prostate cancers: features, detection, localization and staging at endorectal MR imaging. Radiology. 2006;239:784-92.

5. Bratan F, Melodelima C, Souchon R, Hoang Dinh A, Mège-Lechevallier F, Crouzet S, et al. How accurate is multiparametric MR imaging in evaluation of prostate cancer volume? Radiology. 2015;275:144-54.

6. Niaf E, Lartizien C, Bratan F, Roche L, Rabilloud M, Mège-Lechevallier F, et al. Prostate focal peripheral zone lesions: Characterization at multiparametric MR imaging—influence of computer aided diagnosis system. Radiology. 2014;271:761-9.

7. Bloch BN, Furman-Haran E, Helbich TH, Lenkinski RE, Degani H, Kratzik C,et al. Prostate Cancer: accurate determination of extracapsular extension with high spatial resolution dynamic contrast-enhancement and T2-weighted MR imaging-initial results. Radiology. 2007;245:176-85.

8. Borofsky S, George AK, Gaur S, Bernando M, Greer MD, Mertan FV, et al. What are we missing? False-negative cancer at multiparametric imaging of the prostate. Radiology. 2018;286:186-95.

9. Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR. 2007;189:323-8.

10. Canals M, Salas D, Canals A, Siches I, Van Cauwelaert R, Barros R. Valor de la secuencia de difusión en el estudio de cáncer de próstata en pacientes con APE elevado. Rev Chilena de Rad. 2010;16:35-42.

11. Rodriguez A, Gonzalez A, Pita S, Suárez G, Bonelli C, Lorenzo J, et al. Diagnóstico del cáncer de próstata mediante biopsia ampliada de 24 cilindros. Actas Urol Esp. 2015;29:37-42.

12. Hricak H. Imaging prostate cancer, detection/localization using T2WI and DWI. European Congress of Radiology. Vienna, 2018.

13. Lamb BW, Tan WS, Rehman A, Nessa A, Cohen D, O’Neil J, et al. Is pre-biopsy MRI good enough to avoid prostate biopsy? A cohort study over a 1 year period. Clin Genitourin Cancer. 2015;13:512-7.

14. Vilanova JC, Comet J, Garcia- Figueras R, Barceló J, Boada M. Utilidad de la RM en el cáncer de próstata. Radiología. 2010;52(6 ):513-24.

15. Ghai S , Trachtenberg J. MRI-guided biopsies and minimally invasive therapy for prostate cancer. Indian J Urology. 2015;31: 33-42.

16. Fütterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P, et al. Prostate cancer localization with dynamic contrast enhancement MR imaging and proton MR spectroscopic imaging. Radiology. 2006;241:449-58.

17. Rosenkrantz A, Babb J, Taneja S,Ream JM. Proposed adjustments to PI-RADS version 2 decision rules: Impact of prostate cancer detection. Radiology. 2017;283:119-29.